XML 33 R16.htm IDEA: XBRL DOCUMENT
v3.19.1

Derivative Instruments | 12 Months Ended
--- | ---
Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative Instruments | Derivative Instruments As of March 31, 2019, the Company had no outstanding derivative contracts. As of March 31, 2018, the Company had the following derivative contracts recorded at fair value:
| Designated Derivative Contracts |  | Non-Designated Derivative Contracts |  | Total
Notional value | $ | 126,332 |  |  | $ | 4,802 |  |  | $ | 131,134 |
Fair value recorded in other current assets | 950 |  |  | — |  |  | 950 |
Fair value recorded in other accrued expenses | (143 | ) |  | (10 | ) |  | (153 | )
The following table summarizes the effect of Designated Derivative Contracts:
| Years Ended March 31,
| 2019 |  | 2018 |  | 2017
Amount of gain (loss) recognized in OCI (effective portion) | $ | 8,355 |  |  | $ | (9,593 | ) |  | $ | 8,208 |
Amount of gain (loss) reclassified from AOCL into net sales (effective portion) | 8,675 |  |  | (8,541 | ) |  | 7,082 |
Amount of gain excluded from effectiveness testing recognized in SG&A expenses | 1,918 |  |  | 1,376 |  |  | 534 |
The following table summarizes the income tax effect for unrealized gains or losses for Designated Derivative Contracts recorded in AOCL:
| Years Ended March 31,
| 2019 |  | 2018 |  | 2017
Income tax expense (benefit)* | $ | 77 |  |  | $ | 439 |  |  | $ | (423 | )
*These amounts are inclusive of the income tax effects from the Tax Reform Act reclassified from AOCL to retained earnings in the consolidated balance sheets. The following table summarizes the effect of Non-Designated Derivative Contracts:
| Years Ended March 31,
| 2019 |  | 2018 |  | 2017
Amount of gain (loss) recognized in SG&A expenses | $ | 1,393 |  |  | $ | (2,574 | ) |  | $ | 2,202 |
The non-performance risk of the Company and the counterparties did not have a material impact on the fair value of its derivative contracts. During the year ended March 31, 2019, the Designated Derivative Contracts remained effective and that portion of any gain or loss was recognized in AOCL and reclassified into earnings in the same period or periods during which the transaction affected earnings. As of March 31, 2019, there is no unrealized gain or loss on derivative contracts recognized in AOCL. Refer to Note 10, “Stockholders' Equity,” for further information. Subsequent to March 31, 2019 through May 17, 2019, the Company entered into Non-Designated Derivative Contracts with notional values totaling approximately $19,913, which are expected to mature over the next 11 months, and no Designated Derivative Contracts. As of May 17, 2019, the Company’s outstanding hedging contracts were held by an aggregate of two counterparties.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration